Hypera S.A. (BVMF: HYPE3)
Brazil
· Delayed Price · Currency is BRL 18.29
+0.20 (1.11%)
Jan 17, 2025, 6:07 PM GMT-3
Hypera Revenue
Hypera had revenue of 1.92B BRL in the quarter ending September 30, 2024, a decrease of -10.41%. This brings the company's revenue in the last twelve months to 7.78B, down -5.02% year-over-year. In the year 2023, Hypera had annual revenue of 7.91B with 4.88% growth.
Revenue (ttm)
7.78B
Revenue Growth
-5.02%
P/S Ratio
1.50
Revenue / Employee
755.11K
Employees
10,301
Market Cap
11.63B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 7.91B | 368.30M | 4.88% |
| Dec 31, 2022 | 7.55B | 1.61B | 27.10% |
| Dec 31, 2021 | 5.94B | 1.85B | 45.21% |
| Dec 31, 2020 | 4.09B | 794.12M | 24.10% |
| Dec 31, 2019 | 3.29B | -429.56M | -11.53% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rede D'Or São Luiz | 49.35B |
| Raia Drogasil | 37.70B |
| Fleury | 7.55B |
| Odontoprev | 2.38B |
| Blau Farmacêutica | 1.69B |
| Empreendimentos Pague Menos | 12.16B |
| Oncoclínicas do Brasil Serviços Médicos | 6.10B |
| Diagnósticos da América | 14.97B |